Our report shows that miR-147 recovered the EGFR-TKI gefitinib sensitivity of both colon cancer cell line HCT116 and lung cancer cell line A549 cells, which may be related to the inhibition of Akt and induction of other potential genes. The gene discussed is EGFR; the disease is lung cancer.